1. Home
  2. VLY vs GRFS Comparison

VLY vs GRFS Comparison

Compare VLY & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VLY
  • GRFS
  • Stock Information
  • Founded
  • VLY 1927
  • GRFS 1940
  • Country
  • VLY United States
  • GRFS Spain
  • Employees
  • VLY N/A
  • GRFS N/A
  • Industry
  • VLY Major Banks
  • GRFS Biotechnology: Pharmaceutical Preparations
  • Sector
  • VLY Finance
  • GRFS Health Care
  • Exchange
  • VLY Nasdaq
  • GRFS Nasdaq
  • Market Cap
  • VLY 5.2B
  • GRFS 5.9B
  • IPO Year
  • VLY N/A
  • GRFS 2006
  • Fundamental
  • Price
  • VLY $11.43
  • GRFS $8.80
  • Analyst Decision
  • VLY Buy
  • GRFS Hold
  • Analyst Count
  • VLY 14
  • GRFS 1
  • Target Price
  • VLY $12.93
  • GRFS $10.30
  • AVG Volume (30 Days)
  • VLY 9.2M
  • GRFS 771.2K
  • Earning Date
  • VLY 10-23-2025
  • GRFS 01-01-0001
  • Dividend Yield
  • VLY 3.88%
  • GRFS 1.62%
  • EPS Growth
  • VLY 40.78
  • GRFS N/A
  • EPS
  • VLY 0.88
  • GRFS 0.64
  • Revenue
  • VLY $1,704,193,000.00
  • GRFS $8,821,017,248.00
  • Revenue This Year
  • VLY $33.72
  • GRFS $5.31
  • Revenue Next Year
  • VLY $10.10
  • GRFS $6.02
  • P/E Ratio
  • VLY $12.91
  • GRFS $16.95
  • Revenue Growth
  • VLY 8.06
  • GRFS 7.31
  • 52 Week Low
  • VLY $7.48
  • GRFS $6.19
  • 52 Week High
  • VLY $11.51
  • GRFS $11.14
  • Technical
  • Relative Strength Index (RSI)
  • VLY 63.56
  • GRFS 47.98
  • Support Level
  • VLY $10.34
  • GRFS $8.33
  • Resistance Level
  • VLY $11.31
  • GRFS $8.64
  • Average True Range (ATR)
  • VLY 0.33
  • GRFS 0.22
  • MACD
  • VLY 0.05
  • GRFS 0.04
  • Stochastic Oscillator
  • VLY 93.59
  • GRFS 80.14

About VLY Valley National Bancorp

Valley National Bancorp is a bank holding company that offers a full suite of national and regional banking solutions through various commercial, private banking, retail, insurance, and wealth management financial services products. It provides personalized service and customized solutions to assist its customers with their financial service needs. The group also offers niche financial services, including loan and deposit products for homeowners associations, cannabis-related business banking, and venture banking, which offers nationally. It manages its business operations under operating segments consisting of Consumer Banking; Commercial Banking; and Treasury and Corporate Other. The group generates the majority of its revenue from the Commercial Banking Segment.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: